We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

90 hedge funds and large institutions have $276M invested in Cardiovascular Systems, Inc. in 2013 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 39 increasing their positions, 24 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more call options, than puts

Call options by funds: $808K | Put options by funds: $365K

63% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 24

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

2% more funds holding

Funds holding: 8890 (+2)

4% less capital invested

Capital invested by funds: $286M → $276M (-$10.2M)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
90
Holders Change
+2
Holders Change %
+2.27%
% of All Funds
2.92%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.1%
New
11
Increased
39
Reduced
24
Closed
8
Calls
$808K
Puts
$365K
Net Calls
+$443K
Net Calls Change
+$443K
Name Holding Trade Value Shares
Change
Change in
Stake
COPPSERS
51
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$485K
MAM
52
Meeder Asset Management
Ohio
$428K
California Public Employees Retirement System
53
California Public Employees Retirement System
California
$417K +$184K +8,820 +74%
ARTA
54
A.R.T. Advisors
New York
$409K +$426K +20,448 New
HCMT
55
Highland Capital Management (Texas)
Texas
$401K -$209K -10,036 -33%
RhumbLine Advisers
56
RhumbLine Advisers
Massachusetts
$388K -$2K -96 -0.5%
SC
57
Skylands Capital
Wisconsin
$377K +$391K +18,795 New
BCM
58
Bridgeway Capital Management
Texas
$373K -$127K -6,100 -25%
Swiss National Bank
59
Swiss National Bank
Switzerland
$369K
Westfield Capital Management
60
Westfield Capital Management
Massachusetts
$367K
MLICM
61
Metropolitan Life Insurance Company (MetLife)
New York
$361K
CCT
62
Country Club Trust
Missouri
$341K -$332K -15,935 -48%
NFA
63
Nationwide Fund Advisors
Ohio
$333K +$39.1K +1,879 +13%
GGHC
64
Gilder Gagnon Howe & Co
New York
$332K -$1.57M -75,601 -82%
VOYA Investment Management
65
VOYA Investment Management
Georgia
$313K
Citadel Advisors
66
Citadel Advisors
Florida
$307K +$319K +15,304 New
Royal Bank of Canada
67
Royal Bank of Canada
Ontario, Canada
$305K +$17.2K +828 +6%
PPA
68
Parametric Portfolio Associates
Washington
$304K +$316K +15,170 New
AIG
69
American International Group
New York
$281K +$27.5K +1,320 +10%
BA
70
BlackRock Advisors
Delaware
$270K +$13.1K +628 +5%
SCM
71
Stevens Capital Management
Pennsylvania
$270K +$280K +13,462 New
ProShare Advisors
72
ProShare Advisors
Maryland
$265K +$25.1K +1,208 +10%
State Board of Administration of Florida Retirement System
73
State Board of Administration of Florida Retirement System
Florida
$248K
GCP
74
GSA Capital Partners
United Kingdom
$233K -$60K -2,883 -20%
U
75
UBS
Switzerland
$225K -$41.6K -2,000 -15%

CSII Hedge Fund Activity: Q3 2013 in Review

90 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q3 2013, worth a combined $276M — down 3.6% from $286M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new CSII positions and 8 closed out — a net gain of 3 holders — while 39 added to existing stakes and 24 trimmed.

The largest buyer was Consonance Capital Management, adding an estimated $5.32M. The largest seller was Castleark Management, exiting entirely with an estimated $3.35M sold.

  • 90 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q3 2013, up from 88 in Q2 2013.
  • Funds reported $276M of Cardiovascular Systems, Inc. stock for Q3 2013, down 3.6% quarter-over-quarter.
  • 11 funds opened new Cardiovascular Systems, Inc. positions in Q3 2013 and 8 closed out, a net change of +3 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q3 2013 was Consonance Capital Management, an estimated $5.32M added.
  • The largest Cardiovascular Systems, Inc. seller in Q3 2013 was Castleark Management, an estimated $3.35M sold.

Based on aggregated 13F filings for Q3 2013.